The main effect of colloidal bismuth tartrate capsule is to treat peptic ulcer, especially Helicobacter pylori-associated ulcer; it can also be used for chronic colitis, ulcerative colitis, diarrhea, and chronic superficial and atrophic gastritis.
Colloidal bismuth tartrate capsule is gastrointestinal mucosal protection drug, can form a protective layer on the surface of gastrointestinal mucosa, which is conducive to the healing of ulcers and the elimination of inflammation, and can stimulate mucosal epithelial cells to secrete mucus, increase the protection of the mucosa as well as kill Helicobacter pylori, so as to achieve therapeutic effect.
Adverse reactions of colloidal bismuth tartrate capsules are nausea, constipation and other symptoms. Large quantities of long-term use of the drug will appear toxic phenomenon, manifested as the skin is dark brown. If there is black-brown lusterless stools but no other uncomfortable symptoms during the medication, it is a normal phenomenon, and usually returns to normal in 1~2 days after stopping the medication.
In addition, patients who are allergic to the drug components of colloidal bismuth tartrate capsules, patients with renal insufficiency, pregnant women are prohibited, and lactating women should suspend breastfeeding. This drug should not be taken at the same time with acid-making drugs, milk and H2 receptor blocking drugs, otherwise it will reduce the effectiveness of the drug.
If you need to use colloidal bismuth tartrate capsules, it is recommended to consult a professional doctor and follow the doctor’s instructions for standardized treatment, not blindly use the drug on your own.